Pharmacists in Maple Grove, Minnesota


61 Pharmacists found in Maple Grove
female pharmacist

Shelly Zierdt, RPH


Pharmacist
9451 Dunkirk Ln N, Maple Grove, MN 55311
763-416-2300     763-416-2303

female pharmacist

Mrs. Stephanie Jean Petersen, PHARM.D.


Pharmacist
15300 Grove Cir N, T2223, Maple Grove, MN 55369
763-447-2507    

female pharmacist

Susan Marie Redman


Pharmacist
16750 County Road 30, Maple Grove, MN 55311
763-416-1863     763-416-4698



female pharmacist

Sushma S Patel


Pharmacist
17553 64th Pl N, Maple Grove, MN 55311
312-922-2138    

male pharmacist

Tam Minh Phan, PHARMD


Pharmacist
6300 Wedgwood Rd N, Maple Grove, MN 55311
763-551-1215    

male pharmacist

Dr. Tamim Ahmed Saidi, PHARM.D.


Pharmacist
15265 82nd Ave N, Maple Grove, MN 55311
952-567-3991    

male pharmacist

Tanner Mark Ruprecht


Pharmacist
16502 77th Cir N, Maple Grove, MN 55311
763-732-3103    

female pharmacist

Taylor Sheahan, PHARMD


Pharmacist
18755 70th Way N, Maple Grove, MN 55311
763-494-5301    

female pharmacist

Tekla Jay Krebs, PHARMD, R.PH.


Pharmacist
15300 Grove Cir N, Maple Grove, MN 55369
763-447-2507    

male pharmacist

Timothy Blake Markson


Pharmacist
15300 Grove Cir N, Maple Grove, MN 55369
763-447-2507    

female pharmacist

Vandi Jo Anderson, PHARMD


Pharmacist
9875 Hospital Dr, Maple Grove, MN 55369
763-581-1000    

male pharmacist

Vernon D Krueger, RPH


Pharmacist
12880 Elm Creek Blvd N, Maple Grove, MN 55369
763-420-3005     763-420-8624

male pharmacist

Zeleke Belay Goshu, RPH



15300 Grove Cir N, Maple Grove, MN 55369
763-447-2507    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.